The Effects of Age, Endometriosis, Polycystic Ovarium Syndrome, and Obesity on the Success of Embryo Transfer on In Vitro Fertilization
Abstract
Background: One of the important stages in in vitro fertilization (IVF) success is the embryo transfer (ET). Many studies are examining the effect of maternal factors on in vitro fertiliza
References
Dokras A, Baredziak L, Blaine J, Syrop C, VanVoorhis BJ, Sparks A (2006). Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet Gynecol. 108(1): 61
Gonz
Hourvitz A, Machtinger R, Maman E, Baum M, Dor J, Levron J (2009). Assisted reproduction in women over 40 years of age: How old is too old? Reprod Biomed Online. 19(4): 599
Ji J, Liu Y, Tong XH, Luo L, Ma J, Chen Z (2013). The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. Hum Reprod. 28(10): 2728
Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y (1995). High incidence of embryo transfer cancellations in patients with polycystic ovarian syn-drome. Hum Reprod. 10(8): 1962
Langdon F, Pontre J, Hart RJ (2017). Darwish A. Fertility treatment for women with PCOS. Testes and Ovaries: Func-tional and clinical differences and similarities. IntechOpen. doi: 10.5772/intechopen.71188.
Niederberger C, Pellicer A, Cohen J, Gardner DK, Palermo GD, O'Neill CL, Chow S, et al. (2018). Forty Years of IVF. Fertil Steril. 110(2): 185
Ozekinci M, Seven A, Olgan S, Sakinci M, Keskin U, Akar ME, Ceyhan ST, et al. (2015). Does obesity have detrimental effects on IVF treatment outcomes? BMC Womens Health. 15(61): 1
PERFITRI (2017). IVF Registry. Retrieved from https://www.perfitri.org/ivfregistry/.
Prawirohardjo S (2014). Ilmu Kandungan. Edisi ketiga. Jakarta: PT Bina Pustaka Sarwono Prawirohardjo.
Sathya A, Balasubramanyam S, Gupta S, Verma T (2010). Effect of body mass index on in vitro fertilization out-comes in women. J Hum Reprod Sci. 3(3): 135
Singh N, Lata K, Naha M, Malhotra N, Tiwari A, Vanamail P (2014). Effect of endometriosis on implantation rates compared to tubal factor in fresh non donor in vitro fertilization cycles. J Hum Reprod Sci. 7(2): 143
Sirmans SM, Pate KA (2014). Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 6(1): 1
Stadtmauer LA, Toma SK, Riehl RM, Talbert LM (2001). Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin like growth factors. Fertil Steril.
(3): 505
Tan TY, Lau MSK, Loh SF, Tan HH (2014). Female ageing and reproductive outcome in assisted reproduction cycles. Singapore Med J. 55(6): 305
Wolf WM, Wattick RA, Kinkade ON, Olfert MD (2018). Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health. 15(11): 1
Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, et al. (2009). International committee for monitoring assisted reproductive technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 24(11): 2683-2687. doi: 10.1016/j.fertnstert.2009.09.009.
Zhong YP, Ying Y, Wu HT, Zhou CQ, Xu YW, Wang Q, Li J, et al. (2012). Comparison of endocrine profile and in vitro fertilization outcome in patients with PCOS, ovulatory PCO, or normal ovaries. Int J Endocrinol. 2012: 1
